ArticleFrontiers in nutrition2026
Feature-based clustering of hemoglobin trajectories and subsequent risk of end-stage kidney disease in stages 3-4 CKD: a landmark analysis.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Anemia and protein-energy wasting (PEW) are common complications in chronic kidney disease (CKD) and are associated with disease progression. However, the prognostic significance of longitudinal hemoglobin (Hb) trajectory patterns, particularly in the context of nutritional status, remains unclear. This study aimed to identify distinct Hb trajectories in CKD stages 3-4 patients and evaluate their associations with renal outcomes, employing a dual analytical approach: exploratory analysis of concurrent eGFR decline and predictive analysis of subsequent dialysis risk using a landmark design. Methods: This retrospective landmark cohort study included 694 non-dialysis CKD patients from a Japanese medical center. All completed a 2-year landmark period with Hb measured at regular 90-day intervals (± 15 days). Feature-Based Clustering of Longitudinal Trajectories was applied to Hb measurements during the 2-year landmark period to identify trajectory groups. For exploratory association analysis, Cox proportional hazards regression assessed the relationship between Hb trajectories and concurrent ≥30% eGFR decline within the landmark period. For predictive risk stratification, competing risk Fine-Gray regression models (with death as the competing event) evaluated the risk of dialysis initiation occurring after the 2-year landmark period, with trajectory groups serving as baseline predictors. Results: Five distinct Hb trajectory groups were identified: (1) Low-Stable ( Conclusions: Distinct longitudinal Hb trajectories exist in non-dialysis CKD patients and are independently associated with renal progression risk. Maintaining higher, stable Hb levels is associated with delayed renal replacement therapy initiation, whereas rapid Hb decline identifies a high-risk subgroup requiring intensive monitoring and integrated nutritional intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.